Advertisement
Screener

ARMATA PHARMACEUTICALS, INC. (ARMP) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

ARMATA PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets

ARMATA PHARMACEUTICALS, INC. (ARMP) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12

  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.01M, a 17.58% increase year-over-year.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$948.00K.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$194.00K.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.02M, a 318.45% decline year-over-year.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$39.00K.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$5.11M.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$4.83M, a 162.99% decline from fiscal 2022.
  • ARMATA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $7.66M, a 292.92% increase from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$2.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$1.06M
10-Q · filed 2026-08-12
$871.00K
derived: sum of 3 quarters · filed 2026-08-12
-$147.00K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$948.00K
10-Q · filed 2026-05-13
-$1.14M
derived: sum of 2 quarters · filed 2026-05-13
-$2.16M
derived: sum of 3 quarters · filed 2026-05-13
-$448.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$194.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$1.21M
derived: sum of 2 quarters · filed 2026-03-25
$500.00K
derived: sum of 3 quarters · filed 2026-08-12
-$39.00K
10-K · filed 2026-03-25
2025-09-30-$1.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$694.00K
derived: sum of 2 quarters · filed 2026-08-12
$155.00K
10-Q · filed 2025-11-12
-$2.86M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$1.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$1.17M
10-Q · filed 2026-08-12
-$1.84M
derived: sum of 3 quarters · filed 2026-08-12
-$1.37M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$539.00K
10-Q · filed 2026-05-13
-$3.55M
derived: sum of 2 quarters · filed 2026-05-13
-$3.08M
derived: sum of 3 quarters · filed 2026-05-13
-$3.85M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$3.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$2.54M
derived: sum of 2 quarters · filed 2026-03-25
-$3.31M
derived: sum of 3 quarters · filed 2026-03-25
-$5.11M
10-K · filed 2026-03-25
2024-09-30$466.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$298.00K
derived: sum of 2 quarters · filed 2025-11-12
-$2.10M
10-Q · filed 2025-11-12
-$6.99M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$764.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$2.56M
10-Q · filed 2025-08-12
-$7.46M
derived: sum of 3 quarters · filed 2025-08-12
-$9.59M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$1.80M
10-Q · filed 2025-05-14
-$6.70M
derived: sum of 2 quarters · filed 2025-05-14
-$8.83M
derived: sum of 3 quarters · filed 2025-05-14
-$8.04M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$4.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
-$7.03M
derived: sum of 2 quarters · filed 2025-03-21
-$6.24M
derived: sum of 3 quarters · filed 2025-03-21
-$4.83M
10-K · filed 2025-03-21
2023-09-30-$2.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$1.35M
derived: sum of 2 quarters · filed 2024-11-13
$72.00K
10-Q · filed 2024-11-13
$5.38M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$789.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$2.21M
10-Q · filed 2024-08-13
$7.51M
derived: sum of 3 quarters · filed 2024-08-13
$10.31M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$1.42M
10-Q · filed 2024-05-07
$2.10M
10-Q · filed 2023-05-11
$6.73M
derived: sum of 2 quarters · filed 2024-05-07
$9.52M
derived: sum of 3 quarters · filed 2024-05-07
$9.80M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31$5.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
$8.10M
derived: sum of 2 quarters · filed 2024-03-21
$8.38M
derived: sum of 3 quarters · filed 2024-03-21
$7.66M
10-K · filed 2024-03-21
$8.71M
10-K · filed 2023-03-16
2022-09-30$2.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$3.08M
derived: sum of 2 quarters · filed 2023-11-14
$2.35M
10-Q · filed 2023-11-14
$3.48M
10-Q · filed 2022-11-09
$4.07M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$284.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$439.00K
10-Q · filed 2023-08-14
$667.00K
10-Q · filed 2022-08-11
$1.27M
derived: sum of 3 quarters · filed 2023-08-14
$1.14M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$723.00K
10-Q · filed 2023-05-11
$990.00K
derived: sum of 2 quarters · filed 2023-05-11
$858.00K
derived: sum of 3 quarters · filed 2023-05-11
$1.24M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$1.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$1.58M
derived: sum of 2 quarters · filed 2023-03-16
$1.97M
derived: sum of 3 quarters · filed 2023-03-16
$1.95M
10-K · filed 2023-03-16
2021-09-30-$132.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$252.00K
derived: sum of 2 quarters · filed 2022-11-09
$237.00K
10-Q · filed 2022-11-09
$69.00K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$384.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$369.00K
10-Q · filed 2022-08-11
$201.00K
derived: sum of 3 quarters · filed 2022-08-11
$208.00K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$15.00K
10-Q · filed 2022-05-12
-$183.00K
derived: sum of 2 quarters · filed 2022-05-12
-$176.00K
derived: sum of 3 quarters · filed 2022-05-12
$899.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$168.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
-$161.00K
derived: sum of 2 quarters · filed 2022-03-17
$914.00K
derived: sum of 3 quarters · filed 2022-03-17
$994.00K
10-K · filed 2022-03-17
2020-09-30$7.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$1.08M
derived: sum of 2 quarters · filed 2021-11-10
$1.16M
10-Q · filed 2021-11-10
$1.01M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$1.16M
10-Q · filed 2021-08-12
$1.01M
derived: sum of 3 quarters · filed 2021-08-12
$750.00K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$80.00K
10-Q · filed 2021-05-13
-$69.00K
derived: sum of 2 quarters · filed 2021-05-13
-$325.00K
derived: sum of 3 quarters · filed 2021-05-13
-$27.00K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$149.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
-$405.00K
derived: sum of 2 quarters · filed 2021-03-18
-$107.00K
derived: sum of 3 quarters · filed 2021-03-18
-$348.00K
10-K · filed 2021-03-18
2019-09-30-$256.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$42.00K
derived: sum of 2 quarters · filed 2020-11-12
-$199.00K
10-Q · filed 2020-11-12
$181.00K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$298.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
$57.00K
10-Q · filed 2020-08-13
$437.00K
derived: sum of 3 quarters · filed 2020-08-13
$483.00K
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31-$241.00K
10-Q · filed 2020-05-14
$156.00K
10-Q · filed 2019-05-06
$139.00K
derived: sum of 2 quarters · filed 2020-05-14
$185.00K
derived: sum of 3 quarters · filed 2020-05-14
-$188.00K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$380.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19
$426.00K
derived: sum of 2 quarters · filed 2020-03-19
$53.00K
derived: sum of 3 quarters · filed 2020-03-19
$337.00K
10-K · filed 2020-03-19
-$2.00K
10-K · filed 2019-03-25
2018-09-30$46.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$327.00K
derived: sum of 2 quarters · filed 2019-11-12
-$43.00K
10-Q · filed 2019-11-12
$85.00K
10-Q · filed 2018-11-08
-$54.00K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$373.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$89.00K
10-Q · filed 2019-08-14
$69.00K
10-Q · filed 2018-08-09
-$100.00K
derived: sum of 3 quarters · filed 2019-08-14
-$118.00K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$284.00K
10-Q · filed 2019-05-06
$273.00K
derived: sum of 2 quarters · filed 2019-05-06
$255.00K
derived: sum of 3 quarters · filed 2019-05-06
$221.00K
derived: sum of 4 quarters · filed 2019-05-06
2017-12-31-$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
-$29.00K
derived: sum of 2 quarters · filed 2019-03-25
-$63.00K
derived: sum of 3 quarters · filed 2019-03-25
-$381.00K
10-K · filed 2019-03-25
2017-09-30-$18.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$52.00K
derived: sum of 2 quarters · filed 2018-11-08
-$370.00K
10-Q · filed 2018-11-08
-$358.00K
10-Q · filed 2017-11-14
-$666.00K
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30-$34.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$352.00K
10-Q · filed 2018-08-09
-$340.00K
10-Q · filed 2017-08-14
-$648.00K
derived: sum of 3 quarters · filed 2018-08-09
-$654.00K
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$318.00K
10-Q · filed 2018-05-15
-$308.00K
10-Q · filed 2017-05-15
-$614.00K
derived: sum of 2 quarters · filed 2018-05-15
-$620.00K
derived: sum of 3 quarters · filed 2018-05-15
-$610.00K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$296.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$302.00K
derived: sum of 2 quarters · filed 2018-03-14
-$292.00K
derived: sum of 3 quarters · filed 2018-03-14
-$247.00K
10-K · filed 2018-03-14
-$105.00K
10-K · filed 2017-03-27
2016-09-30-$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$4.00K
derived: sum of 2 quarters · filed 2017-11-14
$49.00K
10-Q · filed 2017-11-14
-$215.00K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$55.00K
10-Q · filed 2017-08-14
-$209.00K
derived: sum of 3 quarters · filed 2017-08-14
$63.00K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$45.00K
10-Q · filed 2017-05-15
-$219.00K
derived: sum of 2 quarters · filed 2017-05-15
$53.00K
derived: sum of 3 quarters · filed 2017-05-15
$153.00K
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31-$264.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27
$8.00K
derived: sum of 2 quarters · filed 2017-03-27
$108.00K
derived: sum of 3 quarters · filed 2017-03-27
$182.00K
10-K · filed 2017-03-27
2015-09-30$272.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$372.00K
derived: sum of 2 quarters · filed 2016-11-10
$446.00K
10-Q · filed 2016-11-10
$337.00K
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15
$174.00K
10-Q · filed 2016-08-15
$65.00K
derived: sum of 3 quarters · filed 2016-08-15
-$13.00K
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$74.00K
10-Q · filed 2016-05-12
-$35.00K
derived: sum of 2 quarters · filed 2016-05-12
-$113.00K
derived: sum of 3 quarters · filed 2016-05-12
$68.00K
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31-$109.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-$187.00K
derived: sum of 2 quarters · filed 2016-03-30
-$6.00K
derived: sum of 3 quarters · filed 2016-03-30
$42.00K
10-K · filed 2016-03-30
2014-09-30-$78.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16
$103.00K
derived: sum of 2 quarters · filed 2015-11-16
$151.00K
10-Q · filed 2015-11-16
$108.00K
10-Q · filed 2014-11-14
$147.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$181.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$229.00K
10-Q · filed 2015-08-13
$126.00K
10-Q · filed 2014-09-12
$225.00K
derived: sum of 3 quarters · filed 2015-08-13
$291.00K
derived: sum of 4 quarters · filed 2015-08-13
2014-03-31$48.00K
10-Q · filed 2015-05-15
$109.00K
10-Q · filed 2014-05-20
$44.00K
derived: sum of 2 quarters · filed 2015-05-15
$110.00K
derived: sum of 3 quarters · filed 2015-05-15
-$22.00K
derived: sum of 4 quarters · filed 2015-05-15
2013-12-31-$4.00K
derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15
$62.00K
derived: sum of 2 quarters · filed 2015-04-15
-$70.00K
derived: sum of 3 quarters · filed 2015-04-15
$149.00K
10-Q/A · filed 2015-04-15
$23.00K
10-Q · filed 2014-05-20
2013-09-30$66.00K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-04-15
-$66.00K
derived: sum of 2 quarters · filed 2015-04-15
$153.00K
10-Q/A · filed 2015-04-15
2013-06-30-$132.00K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-04-15
$87.00K
10-Q/A · filed 2015-04-15
2013-03-31$219.00K
10-Q/A · filed 2015-04-15
$222.00K
10-Q · filed 2014-05-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22